Literature DB >> 12810651

Synchrotron photoactivation of cisplatin elicits an extra number of DNA breaks that stimulate RAD51-mediated repair pathways.

Stéphanie Corde1, Jacques Balosso, Hélène Elleaume, Michel Renier, Aurélie Joubert, Marie-Claude Biston, Jean-François Adam, Anne-Marie Charvet, Thierry Brochard, Jean-François Le Bas, François Estève, Nicolas Foray.   

Abstract

Combination of cis-platinum with ionizing radiation is one of the most promising anticancer treatments that appears to be more efficient than radiotherapy alone. Unlike conventional X-ray emitters, accelerators of high energy particles like synchrotrons display powerful and monochromatizable radiation that makes the induction of an Auger electron cascade in cis-platinum molecules [also called photoactivation of cis-platinum (PAT-Plat)] theoretically possible. Here, we examined the molecular consequences of one of the first attempts of synchrotron PAT-Plat, performed at the European Synchrotron Research Facility (Grenoble-France). PAT-Plat was found to result in an extra number of slowly repairable DNA double-strand breaks, inhibition of DNA-protein kinase activity, dramatic nuclear relocalization of RAD51, hyperphosphorylation of the BRCA1 protein, and activation of proto-oncogenic c-Abl tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810651

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Comment to the paper "efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors" from Rousseau et al., in press.

Authors:  Nicolas Foray
Journal:  J Neurooncol       Date:  2010-05-22       Impact factor: 4.130

Review 2.  Microbeam radiosurgery using synchrotron-generated submillimetric beams: a new tool for the treatment of brain disorders.

Authors:  David J Anschel; Alberto Bravin; Pantaleo Romanelli
Journal:  Neurosurg Rev       Date:  2010-11-19       Impact factor: 3.042

Review 3.  The Rationale for "Laser-Induced Thermal Therapy (LITT) and Intratumoral Cisplatin" Approach for Cancer Treatment.

Authors:  Renan Vieira de Brito; Marília Wellichan Mancini; Marcel das Neves Palumbo; Luis Henrique Oliveira de Moraes; Gerson Jhonatan Rodrigues; Onivaldo Cervantes; Joel Avram Sercarz; Marcos Bandiera Paiva
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

4.  Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors.

Authors:  Julia Rousseau; Rolf F Barth; Manuel Fernandez; Jean-François Adam; Jacques Balosso; François Estève; Hélène Elleaume
Journal:  J Neurooncol       Date:  2009-12-11       Impact factor: 4.130

5.  Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation.

Authors:  Julia Rousseau; Caroline Boudou; Rolf F Barth; Jacques Balosso; François Estève; Hélène Elleaume
Journal:  Clin Cancer Res       Date:  2007-08-28       Impact factor: 12.531

6.  Intracerebral delivery of carboplatin in combination with either 6 MV photons or monoenergetic synchrotron X-rays are equally efficacious for treatment of the F98 rat glioma.

Authors:  Laure Bobyk; Magali Edouard; Pierre Deman; Julia Rousseau; Jean-François Adam; Jean-Luc Ravanat; François Estève; Jacques Balosso; Rolf F Barth; Hélène Elleaume
Journal:  J Exp Clin Cancer Res       Date:  2012-09-20

7.  Molecular and cellular response of the most extensively used rodent glioma models to radiation and/or cisplatin.

Authors:  Zuzana Bencokova; Laurianne Pauron; Clément Devic; Aurélie Joubert; Jérôme Gastaldo; Catherine Massart; Jacques Balosso; Nicolas Foray
Journal:  J Neurooncol       Date:  2007-07-05       Impact factor: 4.506

Review 8.  Metal-based NanoEnhancers for Future Radiotherapy: Radiosensitizing and Synergistic Effects on Tumor Cells.

Authors:  Yan Liu; Pengcheng Zhang; Feifei Li; Xiaodong Jin; Jin Li; Weiqiang Chen; Qiang Li
Journal:  Theranostics       Date:  2018-02-12       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.